Home » Topics » BioWorld Science

BioWorld Science
RSS

AtheroGenics initiates phase I testing for new cardiovascular drug

Jan. 27, 1998

Mentor obtains marketing rights to new cancer therapeutic from Intracel

Jan. 27, 1998

New ET antagonists from Merck KGaA bearing a benzothiadiazole functionality

Jan. 27, 1998

First pivotal trial of lisofylline completed

Jan. 27, 1998

Progenitor and Affymetrix collaborate on asthma research

Jan. 27, 1998

New bacterial genomics company established by Theratechnologies

Jan. 27, 1998

New antimigraine combination addresses both headache and vomiting

Jan. 27, 1998

U.K. launch for Posicor

Jan. 27, 1998

Wyeth-Ayerst licenses PEPCK-modulating compounds

Jan. 27, 1998

ACAT-inhibitory anilides from Kowa are particularly useful for atherosclerosis

Jan. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...